N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide
TL;DR: N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide (CAS 536985-97-4) is a chemical compound with molecular formula C21H20N4O3S2 and molecular weight 440.10 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
(E)-N-[5-[2-oxo-2-(2-phenoxyethylamino)ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-3-phenylprop-2-enamide
Also Known As: N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide, (2E)-N-[5-({2-oxo-2-[(2-phenoxyethyl)amino]ethyl}sulfanyl)-1,3,4-thiadiazol-2-yl]-3-phenylprop-2-enamide, (2E)-N-[(2Z)-5-({2-oxo-2-[(2-phenoxyethyl)amino]ethyl}sulfanyl)-1,3,4-thiadiazol-2(3H)-ylidene]-3-phenylprop-2-enamide, (E)-N-[5-[2-oxo-2-(2-phenoxyethylamino)ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-3-phenylprop-2-enamide, N-[5-(2-phenoxyethylcarbamoylmethylsulfanyl)-1,3,4-thiadiazol-2-yl]-3-phenyl-prop-2-enamide
| Molecular Formula | C21H20N4O3S2 |
|---|---|
| Molecular Weight | 440.10 g/mol |
| LogP | 3.4773 |
| Topological Polar Surface Area | 93.21 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 7 |
| Rotatable Bonds | 10 |
| Exact Mass | 440.0977 |
| Heavy Atoms | 30 |
| Complexity | 978.18616 |
Chemical Identifiers
| CAS Number | 536985-97-4 |
|---|---|
| SMILES | C1=CC=C(C=C1)/C=C/C(=O)NC2=NN=C(S2)SCC(=O)NCCOC3=CC=CC=C3 |
Product Overview
N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide (CAS 536985-97-4), with molecular formula C21H20N4O3S2 and molecular weight 440.10 g/mol. IUPAC: (E)-N-[5-[2-oxo-2-(2-phenoxyethylamino)ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-3-phenylprop-2-enamide.
Chemical Property Profile of N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide
Property Insights of N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide
The XLogP value of 3.4773 indicates that N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 93.21 Ų falls within the moderate polarity range, balancing permeability and solubility for N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide. Following Lipinski's Rule of Five, N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide has 2 hydrogen bond donor(s) and 7 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide?
The CAS number of N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide is 536985-97-4.
What is the molecular formula of N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide?
The molecular formula of N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide is C21H20N4O3S2.
What is the molecular weight of N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide?
The molecular weight of N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide is 440.10 g/mol.
Where can I buy N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide?
You can request a quote for N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide?
Yes, KEHONG BIO provides custom synthesis services for N-(5-((2-oxo-2-((2-phenoxyethyl)amino)ethyl)thio)-1,3,4-thiadiazol-2-yl)cinnamamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.